A patient-centred approach to control hypertension at the Primary care level in India (WHO Results Report 2022)

WHO Mid-Term Results Report 2022-2023 Country Impact Story

Non-Communicable Diseases (NCDs), particularly cardiovascular diseases (CVDs), are a major contributor to premature mortality worldwide, with hypertension being especially prevalent in India where an estimated one in four adults suffer from the disease, of which only 10 percent have their blood pressure under control. To help India reach its target of a 25 percent reduction in the prevalence of raised blood pressure, the India Hypertension Control Initiative (IHCI) [1] was launched in November 2017, with the Government of India and state governments providing leadership, and the World Health Organization (WHO) India providing technical assistance. The IHCI was implemented in 141 districts across 25 states, covering 303 million people, resulting in 21 579 health facilities providing support for those suffering from hypertension. Over the past four years, 12.5% of India's estimated hypertensive adult population have been enrolled in the IHCI, with a 72% patient retention rate. This has led to the number of patients with controlled blood pressure increasing from 65 240 in the first quarter of 2019 to 777 243 in the first quarter of 2022.

Read the full impact story by clicking below link.